-
Abstract Number: 0285
Anti-THSD7A Antibodies Are Not Broadly Associated with IgG4-Related Disease or IgG4-Related Membranous Nephropathy
-
Abstract Number: 0286
Damage Associated with Disease-Specific Effects and Diagnostic or Therapeutic Procedures Is Highly Prevalent in IgG4-Related Disease
-
Abstract Number: 0287
Joint Involvement in Cystic Fibrosis: Description of Clinical Phenotypes
-
Abstract Number: 0288
Hypersensitivity Pneumonitis with Autoimmune Features: A New Entity?
-
Abstract Number: 0289
Effectiveness of Rituximab in IgG4 Related Disease
-
Abstract Number: 0290
Deucravacitinib Long-term Efficacy Through 4 Years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program
-
Abstract Number: 0291
Safety of Biologic Therapy in Kidney Transplant Recipients with Inflammatory Diseases: Real-world Experience from a Tertiary Medical Center
-
Abstract Number: 0292
Liver Disease Complicating Familial Mediterranean Fever: A Study on 57 Patients from the French Adult JIR Cohort
-
Abstract Number: 0293
Assessment of Skin Cancer Risk in Autoimmune Diseases: A Multivariate Analysis Using a National Inpatient Database
-
Abstract Number: 0294
Obesity and Risk of Autoimmune Diseases: Insights from the National Inpatient Sample
-
Abstract Number: 0295
Mycophenolate Mofetil in the Treatment of Patients with Isolated Cardiac Sarcoidosis
-
Abstract Number: 0296
Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome
-
Abstract Number: 0297
Characteristics of Adult-Onset Still’s Disease Skin Eruption in Individuals of Sub-Saharan Ancestry
-
Abstract Number: 0298
RAY121, a Novel Recycling Monoclonal Antibody Against Complement C1s: Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase 1a First in Human Clinical Trial in Healthy Adults
-
Abstract Number: 0299
Real-World Tolerability of Nintedanib in Connective Tissue Disease-Associated Interstitial Lung Disease
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 181
- Next Page »